skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?

Original Research

(3126) Views  (440) Full article downloads

Authors:

Jørgen Valeur, Mette Helvik Morken, Elisabeth Norin, et al

Published Date July 2010 Volume 2010:3 Pages 65 - 70
DOI: http://dx.doi.org/10.2147/CEG.S11349

Jørgen Valeur1,2, Mette Helvik Morken1, Elisabeth Norin3, Tore Midtvedt3, Arnold Berstad1,2

1Institute of Medicine, University of Bergen, Bergen, Norway; 2Department of Medicine, Haukeland University Hospital, Bergen, Norway; 3Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

Purpose: Enterometabolic disturbances may cause meal-related symptoms. We performed a functional evaluation of the intestinal microflora in patients with unexplained, self-reported food hypersensitivity by measuring fecal short-chain fatty acids (SCFAs).

Patients and methods: Thirty-five consecutive patients with self-reported food hypersensitivity and 15 healthy volunteers of similar age, gender, and body mass index collected all feces for 72 hours. Fecal concentrations of acetic, propionic, n-butyric, i-butyric, n-valeric, i-valeric, n-caproic, and i-caproic acids were analyzed by gas-liquid chromatography. Concentrations and excretions (output) of SCFAs in patients and controls were compared and related to gastrointestinal symptoms.

Results: Despite nonsignificant differences between patients and controls for both total and individual SCFA concentrations and excretions, n-butyric acid comprised a higher (P = 0.035) and acetic acid a lower (P = 0.012) proportion of total SCFA in patients compared to controls. There were no significant correlations between symptom scores and concentrations or excretions of individual or total SCFAs, but the proportion of n-butyric acid was significantly higher in patients with severe symptoms compared to patients with moderate symptoms (P = 0.016).

Conclusion: The results indicate an enterometabolic disturbance in patients with self-reported food hypersensitivity. Higher proportions of n-butyric acid may be related to abdominal symptom generation, but may also protect against organic bowel disease. Further studies are needed to clarify these aspects.

Keywords: butyrate, dysbiosis, gut microbiota, irritable bowel syndrome, short-chain fatty acids






Readers of this article also read:

Hepatic manifestations of celiac disease
Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation
Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985–2008
Evaluation of therapeutic effects and serious complications following endoscopic obliterative therapy with Histoacryl
Acute gastroenteritis: from guidelines to real life
Irritable bowel syndrome: diagnostic approaches in clinical practice
New and emerging treatments for the prevention of recurrent diverticulitis
Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio